UnitedHealth Group Incorporated [NYSE: UNH] closed the trading session at $489.68 on 06/22/22. The day’s price range saw the stock hit a low of $474.54, while the highest price level was $495.92. The company report on June 22, 2022 that Optum Launches Laboratory Benefit Management Solution to Reduce Unnecessary Testing and Improve Quality of Care.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
The comprehensive solution aligns testing with clinical evidence, helping health plans better manage lab test utilization and spending.
Optum today announced the launch of a comprehensive laboratory benefit management solution designed to help health plans reduce unnecessary lab testing and ensure their members receive appropriate, high-quality tests.
The stocks have a year to date performance of -2.48 percent and weekly performance of 6.05 percent. The stock has been moved at 1.23 percent over the last six months. The stock has performed 0.81 percent around the most recent 30 days and changed -3.10 percent over the most recent 3-months.
If compared to the average trading volume of 3.12M shares, UNH reached to a volume of 5059073 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about UnitedHealth Group Incorporated [UNH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNH shares is $564.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Loop Capital have made an estimate for UnitedHealth Group Incorporated shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 17, 2022. The new note on the price target was released on May 27, 2022, representing the official price target for UnitedHealth Group Incorporated stock. Previously, the target price had yet another raise to $535, while Goldman analysts kept a Buy rating on UNH stock.
The Average True Range (ATR) for UnitedHealth Group Incorporated is set at 14.23, with the Price to Sales ratio for UNH stock in the period of the last 12 months amounting to 1.56. The Price to Book ratio for the last quarter was 6.33, with the Price to Cash per share for the same quarter was set at 26.92. Price to Free Cash Flow for UNH in the course of the last twelve months was 33.70.
UNH stock trade performance evaluation
UnitedHealth Group Incorporated [UNH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.05. With this latest performance, UNH shares gained by 0.81% in over the last four-week period, additionally plugging by 1.23% over the last 6 months – not to mention a rise of 22.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNH stock in for the last two-week period is set at 52.62, with the RSI for the last a single of trading hit 57.34, and the three-weeks RSI is set at 50.49 for UnitedHealth Group Incorporated [UNH]. The present Moving Average for the last 50 days of trading for this stock 498.84, while it was recorded at 468.50 for the last single week of trading, and 471.75 for the last 200 days.
UnitedHealth Group Incorporated [UNH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and UnitedHealth Group Incorporated [UNH] shares currently have an operating margin of +8.33. UnitedHealth Group Incorporated’s Net Margin is presently recorded at +6.01.
Return on Equity for this stock inclined to 25.19, with Return on Assets sitting at 8.30.
Earnings per share (EPS) analysis for UnitedHealth Group Incorporated [UNH] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for UNH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for UnitedHealth Group Incorporated go to 14.62%.
UnitedHealth Group Incorporated [UNH]: Insider Ownership positions
There are presently around $395,479 million, or 89.50% of UNH stock, in the hands of institutional investors. The top three institutional holders of UNH stocks are: VANGUARD GROUP INC with ownership of 80,630,913, which is approximately 1.443% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 69,016,614 shares of the stock with an approximate value of $33.15 billion in UNH stocks shares; and FMR LLC, currently with $23.45 billion in UNH stock with ownership of nearly 1.648% of the company’s market capitalization.
Positions in UnitedHealth Group Incorporated stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 1,446 institutional holders increased their position in UnitedHealth Group Incorporated [NYSE:UNH] by around 29,312,482 shares. Additionally, 1,244 investors decreased positions by around 32,168,744 shares, while 369 investors held positions by with 761,884,962 shares. The mentioned changes placed institutional holdings at 823,366,188 shares, according to the latest SEC report filing. UNH stock had 182 new institutional investments in for a total of 1,460,249 shares, while 91 institutional investors sold positions of 481,650 shares during the same period.